{"DataElement":{"publicId":"5577929","version":"1","preferredName":"Disease or Disorder Veno-Occlusive Disease Sinusoidal Obstruction Syndrome Classification Grade","preferredDefinition":"Sinusoidal Obstruction Syndrome Grade Value Indicator","longName":"DS_VOD_SOS_GRD","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5577881","version":"1","preferredName":"Disease or Disorder Veno-Occlusive Disease Sinusoidal Obstruction Syndrome Classification","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004_A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"2404658v1.00:14101406v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14101406","version":"1","preferredName":"Veno-Occlusive Disease Sinusoidal Obstruction Syndrome Classification","preferredDefinition":"Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004_A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C8301:C26793:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Veno-Occlusive Disease","conceptCode":"C8301","definition":"Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Sinusoidal Obstruction Syndrome","conceptCode":"C26793","definition":"A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"00C99AC7-4998-70E7-E063-731AD00A020A","latestVersionIndicator":"Yes","beginDate":"2023-07-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-07-18","modifiedBy":"KUMMEROA","dateModified":"2023-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"417013D8-8F66-3396-E053-F662850A3AB7","latestVersionIndicator":"Yes","beginDate":"2016-11-16","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-11-16","modifiedBy":"KUMMEROA","dateModified":"2023-07-18","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18 4/21/2021-CDE definition update to human-readable. APAL2020SC","administrativeNotes":"2023.7.18 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4867450","version":"1","preferredName":"Grade","preferredDefinition":"Grade Value Indicator","longName":"GR_IND","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B16945D-0C66-7FC2-E050-BB89AD436137","beginDate":"2015-07-17","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Grade 3","valueDescription":"Grade 3","ValueMeaning":{"publicId":"2568413","version":"1","preferredName":"Grade 3","longName":"2568413","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade 3","conceptCode":"C28079","definition":"A morphologic qualifier indicating that a cancerous lesion is poorly differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D84A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-12","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"18935FCA-D3ED-9638-E050-BB89AD431946","beginDate":"2015-06-15","endDate":null,"createdBy":"LEEW","dateCreated":"2015-06-15","modifiedBy":"ONEDATA","dateModified":"2015-06-15","deletedIndicator":"No"},{"value":"Grade 2","valueDescription":"Grade 2","ValueMeaning":{"publicId":"2568410","version":"1","preferredName":"Grade 2","longName":"2568410","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade 2","conceptCode":"C28078","definition":"A morphologic qualifier indicating that a cancerous lesion is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D847-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-12","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"18935FCA-D3F8-9638-E050-BB89AD431946","beginDate":"2015-06-15","endDate":null,"createdBy":"LEEW","dateCreated":"2015-06-15","modifiedBy":"ONEDATA","dateModified":"2015-06-15","deletedIndicator":"No"},{"value":"Grade 1","valueDescription":"Grade 1","ValueMeaning":{"publicId":"2568409","version":"1","preferredName":"Grade 1","longName":"2568409","preferredDefinition":"No value exists.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade 1","conceptCode":"C28077","definition":"A morphologic qualifier indicating that a cancerous lesion is well differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D846-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-02-12","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"18935FCA-D403-9638-E050-BB89AD431946","beginDate":"2015-06-15","endDate":null,"createdBy":"LEEW","dateCreated":"2015-06-15","modifiedBy":"ONEDATA","dateModified":"2015-06-15","deletedIndicator":"No"},{"value":"Grade 0","valueDescription":"Grade 0","ValueMeaning":{"publicId":"2632183","version":"1","preferredName":"Grade 0","longName":"2632183","preferredDefinition":"Grade 0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EE08824-8AF3-0EAB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-24","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2007-04-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"18935FCA-D418-9638-E050-BB89AD431946","beginDate":"2015-06-15","endDate":null,"createdBy":"LEEW","dateCreated":"2015-06-15","modifiedBy":"ONEDATA","dateModified":"2015-06-15","deletedIndicator":"No"},{"value":"Grade 4","valueDescription":"Grade 4","ValueMeaning":{"publicId":"4756475","version":"1","preferredName":"Grade 4","longName":"4756475","preferredDefinition":"Ulceration.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"LRMSC Grade 4, Skin","conceptCode":"C121173","definition":"Ulceration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1212716F-802D-39B3-E050-BB89AD430F38","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"MAESKEB","dateModified":"2021-04-27","changeDescription":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4171F6EF-17BF-6D8D-E053-F662850A0A61","beginDate":"2016-11-16","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-11-16","modifiedBy":"ONEDATA","dateModified":"2016-11-16","deletedIndicator":"No"},{"value":"Grade 5","valueDescription":"Grade 5","ValueMeaning":{"publicId":"4756476","version":"1","preferredName":"Grade 5","longName":"4756476","preferredDefinition":"Death directly related to radiation late effects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"LRMSC Grade 5, Skin","conceptCode":"C121174","definition":"Death directly related to radiation late effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1212716F-8053-39B3-E050-BB89AD430F38","latestVersionIndicator":"Yes","beginDate":"2015-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-24","modifiedBy":"MAESKEB","dateModified":"2021-04-27","changeDescription":"DCI_Sarcoma QoL Project_03.24.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4171F6EF-17D3-6D8D-E053-F662850A0A61","beginDate":"2016-11-16","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-11-16","modifiedBy":"ONEDATA","dateModified":"2016-11-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2453188","version":"1","preferredName":"Grade","preferredDefinition":"A position on a scale of intensity or amount or quality.","longName":"C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0DDD1E7C-BBFA-66D1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-28","modifiedBy":"ONEDATA","dateModified":"2006-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"18935FCA-D3DB-9638-E050-BB89AD431946","latestVersionIndicator":"Yes","beginDate":"2015-06-15","endDate":null,"createdBy":"LEEW","dateCreated":"2015-06-15","modifiedBy":"MAESKEB","dateModified":"2021-04-27","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18 4/21/2021-CDE definition update to human-readable. APAL2020SC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"What was the maximum grade?","url":null,"context":"COG"},{"name":"Grade:","type":"Preferred Question Text","description":"Grade:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Grade (per protocol version Amendment 2):","url":null,"context":"COG"},{"name":"COG CRF TEXT 4","type":"Alternate Question Text","description":"What is the highest grade of SOS?","url":null,"context":"COG"},{"name":"COG CRF TEXT 3","type":"Alternate Question Text","description":"What is the highest grade during this cycle?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4172E805-F258-7D6B-E053-F662850A1E08","latestVersionIndicator":"Yes","beginDate":"2016-11-16","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-11-16","modifiedBy":"LEEW","dateModified":"2021-04-29","changeDescription":"Workflow and Registration Status changes per Brenda Duggan; 05.16.18 4/21/2021-CDE definition update to human-readable. APAL2020SC","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}